| Serial Number | 79408326 |
| Word Mark | SEAMLESS |
| Filing Date | Thursday, December 14, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, January 13, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Chemicals for use in industry and science; biological preparations for use in industry and science, biological reagents, for use in industry and science, not for medical purposes |
| Indication of Colors claimed | The color(s) green, blue is/are claimed as a feature of the mark. |
| Goods and Services | Scientific and technological services, namely, product research and testing of pharmaceuticals for cell and gene therapies in the field of pharmaceutical product development for the creation of bioinformatic algorithms and models; development of pharmaceutical preparations and medicines, none of the foregoing for diagnostics; pharmaceutical product development, none of the foregoing for diagnostics; pharmaceutical products development of genome editable enzymes for treatment and not diagnostic purposes; pharmaceutical products development of DNA editable enzymes, in particular recombinases and integrases, for treatment and not diagnostic purposes |
| Goods and Services | Pharmaceutical and biological preparations for gene therapies and gene-editing therapies, all for the treatment of genetic and viral diseases; medical, pharmaceutical and biopharmaceutical preparations and substances containing programmable recombinases for the treatment of genetic and viral diseases; pharmaceutical goods and preparations, namely, gene transfer, regulation, modulation and delivery medications for the treatment of genetic and viral diseases and disorders; products, agents, for medical purposes, for veterinary purposes in the nature of pharmaceutical preparations for cellular, genome and gene editing therapies to treat genetic, oncological, immune system-related, and inflammatory disorders and diseases; genome editable enzymes being enzymes for medical purposes; DNA recombinant enzymes being enzymes for medical purposes; DNA editable enzymes, especially, recombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymes, in particular recombinases and integrases, for the treatment of diseases being enzymes for medical purposes; DNA editable enzymes, especially, recombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymes, in particular recombinases and integrases, for the treatment of diseases being enzymes for medical purposes |
| Description of Mark | The mark consists of the wording "SEAMLESS" in stylized font in gradient from blue to green next to the letter "S" comprised of curved bands in green and blue. |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 31, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Seamless Therapeutics GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Event Date | Event Description |
| Thursday, October 31, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, November 4, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 4, 2024 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, November 5, 2024 | ASSIGNED TO EXAMINER |
| Thursday, November 14, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, November 15, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, November 22, 2024 | REFUSAL PROCESSED BY MPU |
| Friday, November 22, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, December 14, 2024 | REFUSAL PROCESSED BY IB |
| Wednesday, May 21, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 21, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 21, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 15, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 15, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 15, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 13, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 13, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 13, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |